Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy

* This is a non-interventional single center, two-arm comparative study of the outcomes for patients following successful, uncomplicated cataract surgery. * There will be 155 subjects enrolled in each arm (310 subjects total). * Consecutive screening will be used for enrollment beginning from the first bilateral IOL implanted. * All testing will be at a single site with subjects coming from 4 surgeons (all use similar surgical technique) at that site. * Each surgeon will contribute a minimum of ten subjects per arm. * Subjects will be assessed post-operatively during a minimum of five months after their second-eye surgery. * Binocular defocus curves will be performed from +1.00 to -4.00 in 0.50 diopter steps and with +0.25 and -0.25 added. * Self-reporting of visual complaints will be assessed. * IOLSAT (IOL Satisfaction) and QUVID (Quality of Vision After Surgery) questionnaire will be administered at the study visit. * Halo and Glare simulator VS Halo \& Glare (visu-med.com) will be administered at the study visit. * All visual acuity testing will be measured in LogMar and all study technicians and evaluators will be masked. * PanOptix subjects will have been implanted with the toric and non-toric models. * Synergy subjects will have been implanted with the toric and non-toric models. * Demographic data will be collected to match the groups as closely as possible.